Mirion Acquires Certrec, a Leader in Regulatory Compliance and Advanced Digital Applications for the Nuclear Industry

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced the acquisition of Certrec, a leading supplier of regulatory compliance and digital integration solutions for the energy industry.

Operating out of Fort Worth, TX, Certrec solutions help ensure a stable and reliable bulk electric supply.

Since 1988, Certrec’s innovation and industry expertise has helped hundreds of power-generating facilities reduce risk and manage regulatory compliance with the Nuclear Regulatory Commission (NRC) and North American Electric Reliability Corporation (NERC). Areas of expertise include licensing, regulatory affairs, compliance, training, and operations, in support of nuclear, fossil, solar, wind facilities, and other types of generating assets. Today, every US nuclear reactor facility employs Certrec solutions, and more than 80 entities in the U.S., Canada and Mexico rely upon Certrec NERC compliance services to decrease regulatory and reputational risk.

“I am delighted to welcome Certrec to the Mirion family,” said Thomas Logan, Mirion’s Chairman and Chief Executive Officer. “The Certrec team brings deep industry relationships and significant software and services capabilities to Mirion that will be pivotal in expanding our offerings in the nuclear power market and further strengthen the development of our digital ecosystem.”

Certrec, joining the Mirion Nuclear & Safety group, is ISO/IEC 27001:2022 certified and has successfully completed annual SOC 2 Type 2 examinations.

The cash purchase price of $81 million plus additional equity incentives granted reflects an acquisition multiple of 16.9x EV/’25E EBITDA for a high-recurring revenue software and services business.

For more information about Certrec, please visit certrec.com.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.